PathGen

is an Indonesia-based biotechnology company that researches and develops molecular diagnostics for the treatment of cancer and other diseases...
Read more
PathGen CEO: Dr Susanti

CEO

Dr Susanti

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?

PathGen Competitors

1DiaCarta
2NeuMoDx
3Sherlock Biosciences
4GenMark
5Circulogene
6Cardiff Oncology
7Caribou
8Boreal Genomics
9Accelerate
10QuantuMDx